The Rising Influence of Rising Affluence

[DewDiligence]

I don’t have a target price on ABT because it’s one of the stocks I intend to hold indefinitely (barring a fundamental change in the business).

In calculating year-over-year results, currency should have a positive effect during most, or all, of 2017. (Since ABT generates about 2/3 of its sales ex-US, currency effects are more consequential than for most S&P 500 companies.)

The recent sell-off relating to the FDA warning is a pretty good entry point, IMO, but ABT isn’t really a stock for traders because the volatility is low.